生物技术与制药领域的最新动态
Thermo Fisher to Purchase Clario to Enhance Clinical Insights and Accelerate Innovation - The Healthcare Technology Report.
Thermo Fisher (NYSE:TMO) Shares Edge Higher on Sector Activity - Kalkine Media
Thermo Fisher Scientific (TMO): Assessing Valuation After FDA Wins Expand Cancer and Diagnostic Offerings - simplywall.st
Thermo Fisher Scientific Stock Prediction: Where Analysts See the Stock Going by 2027 - TIKR.com
Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report? - Yahoo Finance
Thermo Fisher Scientific: Assessing Value After Diagnostics Acquisition and Recent Share Price Gains - simplywall.st
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer - Business Wire
The Bull Case For Thermo Fisher Scientific (TMO) Could Change Following EXENT System Clearance and New Philly Center Opening – Learn Why - Yahoo Finance
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two - PharmTech.com
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing - Morningstar
What Thermo Fisher Scientific (TMO)'s FDA Clearance for EXENT System Means for Shareholders - simplywall.st
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs - citybiz
Thermo Fisher targets early-stage CGT bottlenecks with new Philadelphia hub - R&D World
Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific - Nasdaq
If You Invested $1000 in Thermo Fisher Scientific 10 Years Ago, This Is How Much You'd Have Now - Nasdaq
Rx Rundown: Metagenomi, Chiesi, Thermo Fisher Scientific and more - Medical Marketing and Media
Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma - BioSpace
Finalists in the Thermo Fisher JIC explore biomimicry with SERC - societyforscience.org
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement - simplywall.st